Prostamide-containing intraocular implant
US9289413B2 · kind B2 · utility
4Cited by
5References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 14, 2014 |
| Grant date | Mar 22, 2016 |
| Priority date | — |
| Expiry date | Apr 6, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2430/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Prostamide-containing biodegradable intraocular implants, prostamide compounds, prostamide-containing pharmaceutical compositions, and methods for making and using such implants and compositions for the immediate and sustained reduction of intraocular pressure and treatment of glaucoma in an eye of a patient are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.